Cornell Capital Surpasses Target to Close Second Fund at $1.7 Billion and Expands Senior Leadership in U.S. and Asia
Summary
The fund received strong support from a diverse and global group of existing and new Limited Partners. Leveraging decades of global investment experience, including extensive on-the-ground operating experience in both North America and Asia, Cornell Capitals investment team has particular expertise in identifying and driving cross-border opportunities for the fund and its portfolio companies. "To date, CCP II has completed investments in three companies: Ingenovis Health, a leading tech-enabled healthcare staffing platform; Innovations in Nutrition + Wellness, a formulator and manufacturer of vitamins, minerals and supplements in the health and wellness industry; and Vault, a fast-growing provider of personal insurance for high-net worth clients.Expansion of Senior Leadership in U.S. and AsiaIn support of its continued growth in both the U.S. and Asia, Cornell Capital has recently made a number of senior appointments.Allen Chu has joined the firm as Partner and Head of Asia, where he will work closely with Joyce I-Yin Hsu, who will assume the role of Chair of Asia, to oversee the firms operations and investment activity in the region. Ms. Mason joins from Silver Point Capital, where she held senior marketing and investor relations roles after seven years at KKR & Co., where she worked in the firms Client & Partner Group. Founded in 2013 by Senior Partner Henry Cornell, the former Vice Chairman of Goldman Sachs Merchant Banking Division, the firm is led by a highly seasoned team with significant shared investment experience.